Is MDT a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

5,104 people get MDT articles and Market Currents by email alert.

Get email alerts on MDT »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Focus On Medtronic
Robert Freedland • Tue, Jun 18 • 2 Comments
Medtronic: CoreValve's Long Road To U.S. Approval
Peter Geschek • Wed, Jun 5 • 1 Comment
Assessing A Range Of Valuation Outcomes For Medtronic
Valuentum • Tue, Jun 4
Medtronic And Boston Scientific Are In A Race To Build A Better Pain Device
Peter Geschek • Wed, May 29 • 3 Comments
Dividend Growth Gem Medtronic Is A Cash Cow
Valuentum • Fri, May 24 • 1 Comment
Medtronic's Defibrillator Sales Show A Pulse With Encouraging Results
Trefis • Wed, May 22
Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas
Peter Geschek • Thu, May 16
Billions In Renal Denervation: Medtronic, St. Jude
Peter Geschek • Fri, May 10 • 1 Comment
Medtronic And Sunshine Heart: Pacemaking And Counter-Pulsation - A Tale Of 2 Technologies
Robert Honeywill • Thu, Apr 4
Medtronic Inc. Dividend Stock Analysis
Dividends4Life • Thu, Mar 28 • 2 Comments
Medtronic: The Next Acquisition
Amod Saul • Wed, Mar 27 • 3 Comments
Engager CE Mark Inflames Competition Between Medtronic And Edwards
EP Vantage • Fri, Mar 1
Medtronic Can Give A Portfolio A Boost
Ulfberht Capital • Tue, Feb 26 • 1 Comment
Medtronic Delivering Dividends Through Emerging Markets
Greg Group • Sat, Feb 23 • 6 Comments
Growth Needs Resuscitation, But Medtronic Still Looks Like A Value
Stephen Simpson • Wed, Feb 20 • 3 Comments
Medtronic's Long-Term Plans Unaffected By Short-Term Worries
Vince Martin • Tue, Feb 19 • 2 Comments
Medtronic Earnings Will Highlight Improving Sales Outlook Despite Pricing Pressures
Trefis • Fri, Feb 15
How Medtronic Could Justify A $55 Stock Value
Trefis • Thu, Feb 14
Earnings Analysis: Medtronic Inc.
CapitalCube • Mon, Nov 26, 2012 • 1 Comment
Medtronic - Second Quarter Earnings Confirm Long-Term Investment Thesis
The Value Investor • Sun, Nov 25, 2012 • 1 Comment

Growth Needs Resuscitation, But Medtronic Still Looks Like A Value
Stephen Simpson • Wed, Feb 20 • 3 Comments

Dividend Champions: 8 Increases Expected By Labor Day
David Fish • Tue, Jun 18 • 8 Comments
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Tue, Jun 18 • 61 Comments
3 Reasons Investors Are Yawning At RTI Biologics' Transformational Deal
Alan Brochstein • Wed, Jun 12 • 5 Comments
Which Of The Russell 3000 Healthcare Companies Is Most Attractive To Dividend Investors?
Arie Goren • Mon, Jun 10
How To Play The Invest-For-Tomorrow Game In Medtech: Alan Brochstein
Life Sciences Report • Thu, Jun 6 • 1 Comment
Johnson & Johnson: Part V - Unacceptable Earnings Growth Decline - Reversal Strategy
Robert Honeywill • Thu, Jun 6
Johnson & Johnson - Avoid This Safety Stock
The Ethical Investor • Sun, Jun 2 • 31 Comments
Evaluating Johnson & Johnson's Economic Moat
Daniel Philip • Fri, May 31 • 12 Comments
My Transition To Dividend Growth Investing: A Look Back To Last Summer When It All Began
FinancialStorm • Thu, May 30 • 56 Comments
Will Intuitive Surgical Finally Be Unleashed To Over $700?
Valuentum • Thu, May 30
A So-So Week For Earnings
Bespoke Investment Group • Fri, May 24
Marketo - Demand For Cloud IPOs Sends Valuations To Stratospheric Highs
The Value Investor • Tue, May 21
American Society Of Clinical Oncology Abstracts Point To Potential Profits
David Greene • Tue, May 21 • 3 Comments
The Top 35 Dividend Champions With Regard To Long-Term Stock Price Appreciation
Nicholas Ward • Sun, May 19 • 19 Comments
Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds
Randy Durig • Fri, May 17 • 6 Comments
Dividend Champions: 4 Increases Expected By July 31
David Fish • Thu, May 16 • 1 Comment
Large Hedge Fund Levin Capital's Top Stock Picks
Insider Monkey • Wed, May 15
9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In April
Fredrik Arnold • Mon, May 6
Twenty Dividend Stocks I Recently Purchased For My IRA Rollover
Dividend Growth Investor • Thu, May 2 • 31 Comments
Not All Dividend Increases Are The Same: 2 Dividend Trends That Can Make A Difference
On2Freedom • Tue, Apr 30 • 57 Comments

Medtronic's CEO Presents at Goldman Sachs Healthcare Conference (Transcript)
Thu, Jun 13
Medtronic's CEO Presents at Sanford C Bernstein Strategic Decisions Conference (Transcript)
Fri, May 31
Medtronic's CEO Discusses F4Q 2013 Results - Earnings Call Transcript
Tue, May 21
Medtronic's Management Presents at Barclays Global Healthcare Conference (Transcript)
Wed, Mar 13
Medtronic's Management Presents at Cowen Health Care Conference (Transcript)
Wed, Mar 6
Medtronic's CEO Discusses F3Q 2013 Results - Earnings Call Transcript
Tue, Feb 19
Medtronic's CEO Presents at 31st Annual JPMorgan Healthcare Conference (Transcript)
Mon, Jan 7
Medtronic's CEO Discusses F2Q 2013 Results - Earnings Call Transcript
Tue, Nov 20, 2012
Medtronic Management Discusses Q1 2013 Results - Earnings Call Transcript
Tue, Aug 21, 2012
Medtronic's CEO Hosts 2012 Investor Conference (Transcript)
Sat, Jun 2, 2012 • 2 Comments
Medtronic Management Discusses Q4 2012 Results - Earnings Call Transcript
Tue, May 22, 2012
Medtronic's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Tue, Feb 21, 2012
Medtronic's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Tue, Nov 22, 2011
Medtronic, Inc. Shareholder/Analyst Call
Thu, Aug 25, 2011
Medtronic's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Tue, Aug 23, 2011
Medtronic Management Discusses Q4 2011 Results - Earnings Call Transcript
Tue, May 24, 2011
Medtronic's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Tue, Feb 22, 2011
Medtronic CEO Discusses Q2 2011 Results - Earnings Call Transcript
Tue, Nov 23, 2010
Medtronic CEO Discusses F1Q11 Results - Earnings Call Transcript
Tue, Aug 24, 2010
Medtronic F4Q10 (Qtr End 04/30/2010) Earnings Call Transcript
Tue, May 25, 2010

Movers & Shakers: Tuesday’s movers: Apple falls after Cook testimony

at MarketWatch.com (May 21, 2013)
Stocks Climb on Dovish Fed Comments; Bernanke Up Next

at CNBC.com (May 21, 2013)
Stocks to Watch: Best Buy, Home Depot are Tuesday’s stocks to watch

at MarketWatch.com (May 21, 2013)
Medtronic's 4Q Net Dips 2.2%, Tops Views

at Fox Business (May 21, 2013)
Early Movers: HD, BBY, URBN, DELL & More

at CNBC.com (May 21, 2013)
Market Snapshot: Stock rally’s breadth is a sign of strength, froth

at MarketWatch.com (May 19, 2013)
Big Hair, Big Market, Big Scandals: Talking Squawk

at CNBC.com (May 17, 2013)
Bulls in Control on the Street

at Fox Business (May 3, 2013)
Mark Hulbert: Stocks that perform in bull and bear markets

at MarketWatch.com (Mar 1, 2013)
Dow, S&P End at New 5-Year Highs; GOOG Breaks Above $800

at CNBC.com (Feb 19, 2013)
Medtronic Shares Slump on Disappointing Spinal Sales

at Fox Business (Feb 19, 2013)
Futures Climb, Fueled by M&A Deal Hopes

at CNBC.com (Feb 19, 2013)
Indications: Stock futures rise, anticipating M&A activity

at MarketWatch.com (Feb 19, 2013)
Early Movers: MDT, ODP, OMX & More

at CNBC.com (Feb 19, 2013)
Stocks to Watch: Stocks to Watch: OfficeMax, Dell, Herbalife

at MarketWatch.com (Feb 18, 2013)
UPDATE 3-St. Jude cost cutting pushes Q4 profit above estimates

at CNBC.com (Jan 23, 2013)
UPDATE 2-St. Jude's Q4 profit beats estimates; sees strong 2013

at CNBC.com (Jan 23, 2013)
Claman's Davos Notebook: Who's Who

at Fox Business (Jan 22, 2013)
Lightning Round: Whiting Petroleum, Medtronic and More

at CNBC.com (Jan 3, 2013)
After-Hours Buzz: NFLX, MHP & More

at CNBC.com (Dec 6, 2012)

MDT vs. ETF Alternatives

Company Description

Medtronic is the global leader in medical technology — alleviating pain, restoring health, and extending life for millions of people around the world. We are committed to offering market-leading therapies to restore patients to fuller, healthier lives. With beginnings in the treatment of heart... More

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, June 18, 3:49 AM Medtronic's (MDT) controversial Infuse bone-growth implant for spine surgery is no better than a traditional operation, two independent analyses have found, with the rates of complication similar regardless of the treatment used. Infuse generated $528M in sales in the last fiscal year. Medtronic, which commissioned the studies, had been hit by accusations that doctors who had originally supported Infuse had financial ties to the company worth millions of dollars. 1 Comment [Healthcare]
Monday, June 10, 3:30 PM There is a "better than average chance" Edwards Lifesciences (EW +3.5%) will prevail in a German patent infringement case against Medtronic (MDT +0.1%), Canaccord (Buy) analyst Jason Mills says, adding that an injunction against MDT's CoreValue product "could propel" EW to $85/share. Separately, Credit Suisse upgrades EW to Outperform from Neutral. Comment! [Healthcare, On the Move]
Friday, May 31, 10:53 AM Wedbush initiates several medical equipment and supply names. Rundown: Boston Scientific (BSX +0.8%), which is "progressing with its turnaround story," is started at Neutral (price target $10) with new product intros serving as "catalysts for higher EPS"; Medtronic (MDT) is started at Neutral (price target $52) and is "an 800-lb. gorilla [facing] growing competition, limited near-term growth, and an overextended valuation"; St. Jude Medical (STJ -0.9%) is started at Outperform (price target $57) as the Durata overhang "is beginning to lose some steam enabling investors to refocus on STJ's healthy pipeline." 1 Comment [Healthcare]
Thursday, May 23, 7:24 AM Medtronic (MDT) announces regulatory approval for VIV procedures using CoreValve and CoreValve Evolut TAVI systems in degenerated bioprosthetic surgical aortic valves. It's the first-ever approval for VIV procedures, a minimally-invasive option for at-risk patients. Shares -1% premarket. Comment! [Healthcare]
Tuesday, May 21, 8:39 AM More on Medtronic's (MDT) FQ4: Revenues grow 5% Y/Y on a constant currency basis while non-GAAP EPS growth comes in at 11%. International revenue grows 7% Y/Y and accounts for 47% of total worldwide sales. CEO Omar Ishrak says the results underscore the company's commitment to "delivering consistent and dependable growth." By segment, the Cardiac and Vascular group saw revenues grow 5%, while sales rose 4% in the Resorative Therapies unit. MDT says it sees FY14 revenue grow of 3-4% and EPS of $3.80-$3.82 against consensus of 3.84. Shares +4.25% premarket. (PR) Comment! [Healthcare, Earnings, On the Move]
Tuesday, May 21, 7:20 AM Medtronic (MDT): Q1 EPS of $1.10 beats by $0.07. Revenue of $4.5B beats by $0.11B. 1 Comment [Earnings, Breaking News, Healthcare]
Tuesday, May 21, 12:05 AM Notable earnings before Tuesday’s open: AZO, BBY, DCIX, DKS,HD, MDT, NM, SKS, TJX Comment! [Earnings]
Monday, May 20, 5:30 PM Notable earnings before Tuesday’s open: AZO, BBY, DCIX, DKS,HD, MDT, NM, SKS, TJX Comment! [Earnings]
Friday, May 10, 4:33 PM Medtronic (MDT) says data presented at the Heart Rhythm Society's 34th Annual Scientific Sessions show its Lead Integrity Alert software detected pace/sense lead issues in non-MDT leads at a greater rate than standard impedance monitoring alone. The analysis, which focused on BSX's Endotak leads, shows that for every one Endotak pace/sense lead issue detected by impedance monitoring, the LIA software detected four cases that were missed. Comment! [Healthcare]
Monday, April 29, 3:59 PM Vascular specialists at Carolinas HealthCare System in Charlotte, North Carolina, and the Cleveland Clinic in Ohio perform the initial implants of a novel stent graft system from Medtronic (MDT +1%) as part of an FDA initiative designed to encourage more early-stage clinical research on new medical devices in the U.S. The implants are among the first to be performed under the agency's early feasibility pilot program, which includes a total of nine medical devices from different companies. Comment! [Healthcare]
Monday, April 22, 8:43 AM Arca Biopharma (ABIO) soars 35% premarket. The company says it will collaborate with Medtronic (MDT) on a Phase 2b clinical trial for Gencaro, ABIO's lead developmental drug for the treatment of cardiac rhythm disorders. Comment! [Healthcare, On the Move]
Thursday, April 11, 1:48 PM Medtronic (MDT +1.3%) moves up today after saying it's initiated enrollment of the first patient in its SubQStim II clinical trial which uses peripheral nerve stimulation, also known as subcutaneous nerve stimulation, to reduce chronic, intractable post-surgical back pain. Comment! [Healthcare, On the Move]
Tuesday, April 9, 3:03 PM Medtronic (MDT +1.1%) gains after saying it's released its CardioGuide Implant System, a real-time navigation system for pacemakers and defibrillators in the U.S. and Canada. The system helps physicians determine the most appropriate location for left-ventricular lead placement by generating 3-D images of the cardiac veins. Enhanced software for the system will be commercially available later this year that also analyzes the motion of select cardiac vessels on the left side of the heart. Comment! [Healthcare]
Monday, February 25, 1:51 PM Medtronic (MDT -0.3%) says the FDA has approved the 34mm and 38mm lengths of its Resolute Integrity drug-eluting stent for treating patients with diabetes. The new sizes will enable the treatment of long coronary lesions, which are generally considered to span more than 27mm, and are uniquely indicated for treating coronary artery disease in patients with diabetes, who commonly present with long lesions. Comment! [Healthcare]
Tuesday, February 19, 8:09 AM More on Medtronic (MDT) FQ3: net profit +5.7% to $988M; Sales breakdown: cardiac rhythm disease management -1% excluding currency fluctuations; spinal products -3%. Affirms 2013 guidance for EPS of $3.66-3.70 vs forecasts of $3.68 and revenue growth of 3-4% at constant currencies. Comment! [Healthcare, Earnings]
Tuesday, February 19, 7:30 AM Medtronic (MDT): FQ3 EPS of $0.93 beats by $0.02. Revenue of $4.03B (+3% Y/Y) in-line. (PR) Comment! [Earnings, Breaking News, Healthcare]

Nathaniel Matherson
New Article: "Finding Strength in Healthcare Supplies" http://bit.ly/12RUEvG $MCK $MDT $HSIC
Mon, 11:46 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Nathaniel Matherson
New Post "Profiting From Diabetes Expenses" on Circa Alpha: http://bit.ly/1b8V5zm $MDT $LLY
Jun 6, 10:55 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Andrew Shapiro
LA Times Op-Ed: Why the medical device tax needs to stay #MDET $JNJ $MDT http://ow.ly/lCpGa
Jun 2, 12:21 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

The Aristos
$MDT needs to increase dividend to $.30+ to maintain pace of stock price. No longer a great dividend stock in my eyes at a 2% yield.
May 16, 10:49 AM
Reply (4)

• !Report Abuse
View all 4 replies
Dividend Growth Machine: Understood. I'm guessing they'll do a 7.7% increase to $0.28 per share, which would be satisfactory for me (I am long MDT).
May 16, 11:12 AM
• !Report Abuse
The Aristos: Was long from early 2012. Sold in April. Probably over-thinking it yet put that money in more undervalued names.
May 16, 1:20 PM
• !Report Abuse
Add a reply...

140 characters

Dividend Growth Investor
Attractively valued dividend stocks to consider today http://bit.ly/12yCjOY $CVX $XOM $AMP $AFL $APD $BDX $WMT $UTX $TGT $MDT
May 14, 6:49 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dividend Sheet
$TROW $FTR and $HCP are the most profitable Dividend Champions - http://stks.co/dTVp - 20 shares with 2.6% average yield $SIAL $MDT $MHFI
May 9, 2:37 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dividend Sheet
$PDLI $WCRX and $QCOR are the best Yielding Cheap Healthcare Dividend Stocks - http://stks.co/dSSu - 20 stocks 2.66% at Yield $MDT $PFE
May 2, 2:51 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

REHeakins
$MDT looks like it is finding support at its 50 day moving avg.
Apr 18, 3:47 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
This Week's Potential Downgrades (continued): $LOW, $LYB, $MCRS, $MDT, $MET, $NE, $NSR, $NUE, $OAS, $OKS, $OXY, $PNC, $PRU, $ROSE
Mar 4, 3:04 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Kwimo
Sold $MDT at 44.87 (bought yesterday at 43.74). http://seekingalpha.com/s/c89lb
Feb 28, 9:50 AM
Reply (2)

• !Report Abuse
View all 2 replies
Kwimo: Still have original long term position from last summer.
Feb 28, 9:55 AM
• !Report Abuse
Kwimo: *Bought 2 days ago, not yesterday.
Feb 28, 1:20 PM
• !Report Abuse
Add a reply...

140 characters

LATEST REPLIES

Dr. Kris
Medical devices etf $IHI breaking out to new all-time high on 2.7x volume. Top holdings: $MDT, $COV, $TMO, $ISRG, $SYK....
Jan 9, 2:23 PM
Reply (5)

• !Report Abuse
View all 5 replies
Dr. Kris: Bob: I'm dubbing you the official SA music director. Each stock should have its own theme song.
Jan 9, 2:59 PM
• !Report Abuse
techwonk: $MZOR rising 12% today on unusual volume
Mon, 4:23 PM
• !Report Abuse
Add a reply...

140 characters

The Aristos
$MDT needs to increase dividend to $.30+ to maintain pace of stock price. No longer a great dividend stock in my eyes at a 2% yield.
May 16, 10:49 AM
Reply (4)

• !Report Abuse
View all 4 replies
Dividend Growth Machine: Understood. I'm guessing they'll do a 7.7% increase to $0.28 per share, which would be satisfactory for me (I am long MDT).
May 16, 11:12 AM
• !Report Abuse
The Aristos: Was long from early 2012. Sold in April. Probably over-thinking it yet put that money in more undervalued names.
May 16, 1:20 PM
• !Report Abuse
Add a reply...

140 characters

Kwimo
Sold $MDT at 44.87 (bought yesterday at 43.74). http://seekingalpha.com/s/c89lb
Feb 28, 9:50 AM
Reply (2)

• !Report Abuse
View all 2 replies
Kwimo: Still have original long term position from last summer.
Feb 28, 9:55 AM
• !Report Abuse
Kwimo: *Bought 2 days ago, not yesterday.
Feb 28, 1:20 PM
• !Report Abuse
Add a reply...

140 characters

Kwimo
Bought some $MDT at $43.74.
Feb 26, 10:26 AM
Reply (2)

• !Report Abuse
View all 2 replies
Kwimo: It's just an add to a long term position that I've had since last summer. This portion won't be long term.
Feb 26, 10:28 AM
• !Report Abuse
Kwimo: MDT up nicely today. Put in breakeven stop for this parcel.
Feb 27, 10:08 AM
• !Report Abuse
Add a reply...

140 characters

Tony Kau
Lots of viable Put credit spreads right now... $POT $CF $JWN $WLT $MDT $DDS http://stks.co/aLoe http://ow.ly/i/1A9HR
Feb 25, 3:32 PM
Reply (2)

• !Report Abuse
View all 2 replies
SKS1586: Awesome stock list TONY. Good-Luck to create 100% winners (IMO possibility is near 100%)
Feb 25, 10:06 PM
• !Report Abuse
Tony Kau: Thanks! Yes, trying to get in always 85%+, usually 90%+ chance of profit, with decent premiums... Cheers!
Feb 26, 1:08 AM
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
Long Medtronic (MDT) at $38.15 and the pain in suffering of selling AUTH just before the AAPL buyout http://bit.ly/LSa612
7/27/12
Reply (11)

• !Report Abuse
View all 11 replies
Maria Auziliadora: made 640 in ARUN
8/23/12
• !Report Abuse
Maria Auziliadora: this market is crazy
8/23/12
• !Report Abuse
Add a reply...

140 characters

Maria Auziliadora
GO MDT new high today
8/20/12
Reply (14)

• !Report Abuse
View all 14 replies
Maria Auziliadora: thank you losbronces
8/20/12
• !Report Abuse
Maria Auziliadora: I am careful
8/20/12
• !Report Abuse
Add a reply...

140 characters

The_American
GSK DNDN TNGN.OB CTIC STEM should ALL be looked at into the BIB space and PFE MRK GSK should be looking into much more MDT also looking AMRS X
4/21/12
Reply (6)

• !Report Abuse
View all 6 replies
The_American: No long GLD GSK starred at it long NUGT Miners showing bottom GDX GDXJ GLDX RING and GGGG The GLD IAU SLV AGQ DBS CEF MUX HL SWC DIA QQQ AA
5/18/12
• !Report Abuse
The_American: No long GLD GSK starred at it long NUGT Miners showing bottom GDX GDXJ GLDX RING and GGGG The GLD IAU SLV AGQ DBS CEF MUX HL SWC DIA QQQ AA
5/18/12
• !Report Abuse
Add a reply...

140 characters

Jacob Wolinsky
America's Best Companies are Cheap http://bit.ly/sbXkGk $ABT AVP $BBY $CVX $ENDP $EZPW $FISV GME $HPG $INTC IR ItW JNJ $MDT SYK TEVA LLL
12/19/11
Reply (2)

• !Report Abuse
View all 2 replies
Clayton Rulli: BBY sux.. TEVA an american company? Its based in Israel
12/19/11
• !Report Abuse
Jacob Wolinsky: Its an ADR
12/19/11
• !Report Abuse
Add a reply...

140 characters

MDT Medtronic Inc.

MDT

Medtronic Inc.